Hyderabad (Press statement): Bharat Biotech, a global leader in vaccine innovation and developer of vaccines for infectious diseases, today announced results from a study conducted at Emory University demonstrating that sera from subjects who received a booster dose of COVAXIN® (BBV152) six months after getting a primary two-dose series of COVAXIN® (BBV152), neutralized the SARS-CoV-2 Omicron and Delta variants. Earlier studies demonstrated the neutralizing potential of COVAXIN® (BBV152) agai...Read More

Gandhinagar: Union health minister Mansukh Mandaviya will be on his Gujarat visit on August 29 visit Bharat Biotech's vaccine manufacturing unit at Ankleshwar in Central Gujarat and release the first batch of Covaxin manufactured in this plant. Gujarat BJP Chief CR Patil will remain present on this occasion. DeshGujarat Read More

Hyderabad: Bharat Biotech today in a statement said: The manufacturing, testing, release and distribution of vaccines is a complex and multifactorial process with hundreds of steps, requiring a diverse pool of human resources. For vaccines to result in actual vaccination of people, highly coordinated efforts are required from international supply chain, manufacturers, regulators and State and Central government agencies. Production scale-up of vaccines is a step-by-step process, involving sev...Read More

Hyderabad: Bharat Biotech today announced the quick ramp up of additional manufacturing capacities for Covaxin at Chiron Behring vaccines, Ankleshwar, Gujarat, a wholly owned subsidiary of Bharat Biotech. The company plans to produce 200 millions doses of Covaxin per annum in the GMP facilities that are already operational for the production of vaccines based on Inactivated Vero Cell Platform Technology, under stringent levels of GMP and biosafety. Product availability at Ankeshwar to commenc...Read More